Therapeutic options in small abdominal aneurysms: the role of in vitro studies.
Thompson
M M
MM
Department of Surgery, University of Leicester, UK. MattT11@aol.com
Boyle
J R
JR
Crowther
M
M
Goodall
S
S
Wills
A
A
Loftus
I M
IM
Bell
P R
PR
D017311:Amlodipine / Q000627:therapeutic use*; D000818:Animals; D001013:Aorta, Thoracic / Q000201:enzymology*; D017544:Aortic Aneurysm, Abdominal / Q000188:drug therapy* / Q000201:enzymology; D017364:Collagenases / Q000096:biosynthesis; D004318:Doxycycline / Q000627:therapeutic use*; D018093:Gelatinases / Q000096:biosynthesis; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D008955:Models, Cardiovascular; D009924:Organ Culture Techniques; D010196:Pancreatic Elastase / Q000378:metabolism / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology*; D013552:Swine
D011480:Protease Inhibitors; D017311:Amlodipine; D010196:Pancreatic Elastase; D017364:Collagenases; D018093:Gelatinases; D008666:Metalloendopeptidases; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D004318:Doxycycline